190 related articles for article (PubMed ID: 24381574)
1. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
2. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
3. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
4. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
5. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
[TBL] [Abstract][Full Text] [Related]
6. HLA-DMA polymorphisms differentially affect MHC class II peptide loading.
Álvaro-Benito M; Wieczorek M; Sticht J; Kipar C; Freund C
J Immunol; 2015 Jan; 194(2):803-16. PubMed ID: 25505276
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
8. The Other Function: Class II-Restricted Antigen Presentation by B Cells.
Adler LN; Jiang W; Bhamidipati K; Millican M; Macaubas C; Hung SC; Mellins ED
Front Immunol; 2017; 8():319. PubMed ID: 28386257
[TBL] [Abstract][Full Text] [Related]
9. HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.
Yin L; Stern LJ
Front Immunol; 2013 Oct; 4():336. PubMed ID: 24146666
[TBL] [Abstract][Full Text] [Related]
10. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
[TBL] [Abstract][Full Text] [Related]
11. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
[TBL] [Abstract][Full Text] [Related]
12. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.
Guce AI; Mortimer SE; Yoon T; Painter CA; Jiang W; Mellins ED; Stern LJ
Nat Struct Mol Biol; 2013 Jan; 20(1):90-8. PubMed ID: 23222639
[TBL] [Abstract][Full Text] [Related]
13. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
14. HLA-DM: arbiter conformationis.
Ferrante A
Immunology; 2013 Feb; 138(2):85-92. PubMed ID: 23113687
[TBL] [Abstract][Full Text] [Related]
15. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
16. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers.
Draghi NA; Denzin LK
Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16607-12. PubMed ID: 20807742
[TBL] [Abstract][Full Text] [Related]
17. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
Ferrari G; Knight AM; Watts C; Pieters J
J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
[TBL] [Abstract][Full Text] [Related]
18. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
[TBL] [Abstract][Full Text] [Related]
19. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
Vogt AB; Kropshofer H; Hämmerling GJ
Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
[TBL] [Abstract][Full Text] [Related]
20. Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of
Graves AM; Virdis F; Morrison E; Álvaro-Benito M; Khan AA; Freund C; Golovkina TV; Denzin LK
J Immunol; 2020 Aug; 205(4):923-935. PubMed ID: 32690655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
